The role of D-Cycloserine in combination with exposure therapy in the treatment of Panic Disorder to improve the severity of panic symptoms.

Recruiting

• Conditions: Panic Disorder; Mental Health - Other mental health disorders

• Registration Number: ACTRN12606000351516
• Lead Sponsor: niversity of New South Wales

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2006-08-16
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Primary diagnosis of Panic Disorder.

Exclusion Criteria

Epilepsy, severe kidney disease, use of contraindicated medications, suicide intent, substance dependence and pregnancy.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Severity of Panic Symptoms[Assessed immeidately after the three week intervention, one month and three months post intervention dated from the end of the three weeks of therapy.]

Secondary Outcome Measures

Name	Time	Method
Global functioning such as their general health, depression and stress levels and current diagnosis.[Assessed immediately after the three week intervention and one month and three months post intervention dated from the end of the three weeks of therapy.]